Cell and Gene Therapy Development
Streamline CGT Manufacturing Processes
Genedata Selector enables automation and standardization of NGS-based cell and gene therapy assays.
This out-of-the-box support includes safety assays, sequence characterization, and potency assessment.
Ensure Biosafety of CGTs
When used with NGS data, Genedata Selector provides a comprehensive solution for detecting adventitious agents throughout the CGT development process.
From raw the material to the final product, our platform helps you to ensure the biosafety of cell and gene therapy.
Confirm the Integrity of Viral Vectors
Decision making support provided by Genedata Selector leads to faster and better informed decisions for safe cell and gene therapy development.
Scientists can verify sequence integrity of viral vectors in a simple and automated way.
Assess Potency with scRNAseq Analysis
Genedata Selector supports single cell RNAseq data analyses to streamline your decision-making using the informative and interactive data display.
Cell populations can be analyzed regarding identity and determine the potency.